Unicycive Therapeutics (UNCY) News Today $4.19 -0.01 (-0.24%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$4.20 +0.01 (+0.21%) As of 08/29/2025 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock UNCY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Faruqi & Faruqi Reminds Unicycive Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2025 – UNCYAugust 29 at 11:05 AM | globenewswire.comUnicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights – UNCYAugust 28 at 4:44 PM | globenewswire.comInvestors who lost money on Unicycive Therapeutics, Inc.(UNCY) should contact The Gross Law Firm about pending Class Action - UNCYAugust 28 at 8:45 AM | prnewswire.comShareholders of Unicycive Therapeutics, Inc. Should Contact The Gross Law Firm Before October 14, 2025 to Discuss Your Rights – UNCYAugust 27 at 4:32 PM | globenewswire.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive TherapeuticsAugust 27 at 10:30 AM | prnewswire.comPomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCYAugust 27 at 10:00 AM | prnewswire.comKaplan Fox Alerts Unicycive Therapeutics, Inc. (UNCY) Investors to a Securities Class Action Lawsuit - Deadline is October 14, 2025August 27 at 7:40 AM | theglobeandmail.comUnicycive Therapeutics, Inc. (UNCY) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of October 14, 2025 DeadlineAugust 27 at 7:40 AM | theglobeandmail.comHead to Head Contrast: Unicycive Therapeutics (NASDAQ:UNCY) vs. Protara Therapeutics (NASDAQ:TARA)August 27 at 4:45 AM | americanbankingnews.comLost Money on Unicycive Therapeutics, Inc. (UNCY)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyAugust 27 at 2:39 AM | theglobeandmail.comUNCY Investors with Large Losses Should Contact Robbins LLP for Information About Leading the Unicycive Therapeutics, Inc. Class ActionAugust 26, 2025 | globenewswire.comClass Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking Recovery for Investors - Contact Levi & KorsinskyAugust 26, 2025 | prnewswire.comShareholders that lost money on Unicycive Therapeutics, Inc.(UNCY) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreAugust 26, 2025 | prnewswire.comUnicycive Therapeutics to Participate in Upcoming Investor Events in SeptemberAugust 26, 2025 | globenewswire.comShareholders of Unicycive Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCYAugust 25, 2025 | theglobeandmail.comLevi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Unicycive Therapeutics, Inc.(UNCY) ShareholdersAugust 25, 2025 | globenewswire.comPomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers – UNCYAugust 25, 2025 | globenewswire.comUnicycive Therapeutics (NASDAQ:UNCY) Downgraded by Wall Street Zen to "Sell"August 25, 2025 | marketbeat.comUNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Unicycive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitAugust 24, 2025 | globenewswire.comUNICYCIVE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Unicycive Therapeutics, Inc. and Encourages Investors to Contact the FirmAugust 23, 2025 | globenewswire.comWall Street Zen Downgrades Unicycive Therapeutics (NASDAQ:UNCY) to SellAugust 23, 2025 | americanbankingnews.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 14, 2025 in Unicycive Therapeutics, Inc. Lawsuit – UNCYAugust 22, 2025 | globenewswire.comSHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive TherapeuticsAugust 22, 2025 | globenewswire.comKaplan Fox Alerts Investors of Unicycive Therapeutics, Inc. (UNCY) to a Securities Class Action Deadline on October 14, 2025August 22, 2025 | theglobeandmail.comPomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCYAugust 22, 2025 | prnewswire.comUnicycive Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCYAugust 22, 2025 | prnewswire.comClass Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join – Contact The Gross Law FirmAugust 21, 2025 | globenewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive TherapeuticsAugust 21, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCYAugust 21, 2025 | globenewswire.comShareholders that lost money on Unicycive Therapeutics, Inc.(UNCY) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreAugust 21, 2025 | prnewswire.comShareholders who lost money in shares of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Should Contact Wolf Haldenstein Immediately.August 21, 2025 | prnewswire.comShareholders who lost money in shares of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Should Contact Wolf Haldenstein ImmediatelyAugust 20, 2025 | globenewswire.comUNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Unicycive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitAugust 20, 2025 | prnewswire.comUnicycive Therapeutics granted new U.S. patent for UNI-494 to treat CKDAugust 19, 2025 | msn.comUnicycive Therapeutics, Inc.: Unicycive Therapeutics Granted New U.S. Patent for UNI-494 to Treat Chronic Kidney DiseaseAugust 19, 2025 | finanznachrichten.deUnicycive Posts 65% EPS Gain in Q2August 19, 2025 | theglobeandmail.comUNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Unicycive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitAugust 18, 2025 | globenewswire.comUNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. ...August 18, 2025 | gurufocus.comUNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmAugust 18, 2025 | businesswire.comSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive TherapeuticsAugust 18, 2025 | businesswire.comGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Unicycive Therapeutics, Inc. (UNCY)August 18, 2025 | globenewswire.comINVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Unicycive Therapeutics (UNCY) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the FirmAugust 18, 2025 | globenewswire.comUnicycive Therapeutics Granted New U.S. Patent for UNI-494 to Treat Chronic Kidney DiseaseAugust 18, 2025 | globenewswire.comInvestor Alert: Robbins LLP Informs Investors of the Unicycive Therapeutics, Inc. Class ActionAugust 18, 2025 | gurufocus.comInvestor Alert: Robbins LLP Informs Investors of the Unicycive Therapeutics, Inc. Class ActionAugust 18, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCYAugust 17, 2025 | globenewswire.comUnicycive Therapeutics (NASDAQ:UNCY) Posts Quarterly Earnings Results, Beats Expectations By $0.18 EPSAugust 16, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCYAugust 16, 2025 | prnewswire.comUnicycive Therapeutics Raises $16.3 Million in Stock SaleAugust 15, 2025 | msn.comUnicycive Therapeutics reports Q2 EPS (52c), consensus (70c)August 14, 2025 | msn.com Get Unicycive Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for UNCY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. UNCY Media Mentions By Week UNCY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. UNCY News Sentiment▼0.101.05▲Average Medical News Sentiment UNCY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. UNCY Articles This Week▼223▲UNCY Articles Average Week Get the Latest News and Ratings for UNCY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Unicycive Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Ocugen News Cartesian Therapeutics News Atea Pharmaceuticals News Neurogene News Lifecore Biomedical News Aurora Cannabis News Contineum Therapeutics News Vor Biopharma News DBV Technologies News Mereo BioPharma Group News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:UNCY) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unicycive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Unicycive Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UNCY Stock Alerts